Orbus Therapeutics
PrivateLast Round
Series A
Extension
Oct 22, 2020
Total Funding Raised
$71M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Orbus Therapeutics is a biopharmaceutical company that develops and commercializes therapeutic products for rare diseases, with a focus on treatments for brain tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Orbus Therapeutics Comparables
Compare Orbus Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Laminar Pharmaceuticals | 78% | |
| Kazia Therapeutics | 77% | |
| Panbela Therapeutics | 76% |
Orbus Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Oct 22, 2020 | ||||
| Series A | Aug 19, 2015 |
Orbus Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Longitude Capital | Series A Extension, Series A |
| HIG BioHealth Partners | Series A Extension, Series A |
| Abingworth | Series A Extension |
| Adams Street Partners | Series A Extension, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 96% MoM, reaching 2.9K.
- Jul 25, 2026
Monthly visitors increased 40% MoM.
Orbus Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Orbus Therapeutics's valuation, stock price, and market status.
Is Orbus Therapeutics a public or private company?
Orbus Therapeutics is a private company.
What is the current stock price of Orbus Therapeutics?
Orbus Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Orbus Therapeutics worth (valuation)?
Valuation information for Orbus Therapeutics is not publicly available.
Can I buy Orbus Therapeutics stock?
Orbus Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Orbus Therapeutics's last funding round?
Orbus Therapeutics's most recent funding round was Series A Extension on October 22, 2020.
Who are the main investors in Orbus Therapeutics?
Key investors in Orbus Therapeutics include Longitude Capital, HIG BioHealth Partners, Adams Street Partners.
Will Orbus Therapeutics IPO soon?
No public IPO plans have been announced for Orbus Therapeutics.
How can I track Orbus Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Orbus Therapeutics's secondary market activity and sign up for updates.